Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2023 03:00 ET | Source: Sitryx Therapeutics

Sitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases

Lilly exercises option to an exclusive worldwide license to develop and commercialize SIT-011, a Phase 1 ready immunometabolism-targeting therapy for chronic autoimmune and inflammatory...